Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Mumps Measles Rubella Varicella
NITAG recommendation Recommendation United States of America Diphtheria Tetanus Pertussis
Download:
Coverage Newborn (0-1 years) Children (2-9 years) Mumps Diphtheria Tetanus Pertussis Measles Rubella Poliomyelitis
Administration Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Economic aspects Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Rotavirus
Agenda & Minutes Argentina Measles
Download:
Agenda & Minutes Argentina Measles Poliomyelitis Meningitis Yellow fever
Download: